Liver transplantation for acute liver failure - Better safe than sorry

Liver Transplantation

Volumn 8, Issue 11, 2002, Pages 1063-1064

  Schiødt, Frank Vinholt ^a   Lee, William M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL;

CONTROLLED STUDY; COST OF ILLNESS; EDITORIAL; EMERGENCY SURGERY; HEPATIC ENCEPHALOPATHY; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; ORGAN DONOR; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

EID: 0036851231     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.35850     Document Type: Article

References (22)

1. Schafer DF, Shaw BW. Fulminant hepatic failure and orthotopic liver transplantation. Semin Liver Dis 1989;9:189-194.
2. Lee WM, Schiødt FV. Fulminant hepatic failure. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver. Philadelphia: Lippincott-Raven; 1999: 879-895.
3. Brandsaeter B, Hockerstedt K, Friman S, Ericzon B-G, Kirkegaard P, Isoniemi H, et al. Fulminant hepatic failure. Outcome after listing for highly urgent liver transplantation. Twelve years experience in the Nordic countries. Liver Transpl 2002;8:1055-1062.
4. Ostapowicz G, Fontana RJ, Navarro VJ, Chung RT, Torres MB, Atillasoy E, et al. Use of liver transplantation in patients with acute liver failure[abstr]. Hepatology 2000;32:214.
5. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998;27:1050-1055.
6. O'Grady JG, Wendon JA, Tan KC, Potter D, Cottam S, Cohen AT, et al. Liver transplantation after paracetamol overdose. BMJ 1991;303:221-223.
7. Schiødt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5:29-34.
8. Ostapowicz G, Fontana RJ, Larson AM, Davern T, Lee WM, ALF Study Group. Etiology and outcome of acute liver failure in the USA: Preliminary results of a prospective multi-center study [abstr]. Hepatology 1999:30:221A.
9. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002;359:558-563.
10. Schiødt FV, Lee WM. Management of acetaminophen toxicity. In: Krawitt EL, ed. Medical Management of Liver Disease. New York: Marcel Dekker; 1999: 325-337.
11. Ritt DJ, Whelan G, Werner DJ, Eigenbrodt EH, Schenker S, Combes B. Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients. Medicine 1969;48:151-172.
12. Rakela J, Lange SM, Ludwig J, Baldus WP. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc 1985;60: 289-292.
13. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
14. Bernuau J, Samuel D, Durand F, Saliba F, Bourliere M, Adam R, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: A prospective study[abstr]. Hepatology 1991;14:49A.
15. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995;222:109-119.
16. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol 1993;17:124-127.
17. Schiødt FV, Bondesen S, Petersen I, Dalhoff K, Ott P, Tygstrup N. Admission levels of serum Gc-globulin: Predictive value in fulminant hepatic failure. Hepatology 1996;23:713-718.
18. Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993;18:1370-1374.
19. Ranek L, Andreasen PB, Tygstrup N. Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut 1976;17:959-964.
20. Christensen E, Bremmelgaard A, Bahnsen M, Andreasen PB, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 1984;19:90-96.
21. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver diseases. New York: Grune & Stratton; 1970: 282-298.
22. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993;342:273-275.